Characterization of fibrillar collagens and extracellular matrix of glandular benign prostatic hyperplasia nodules
- PMID: 25275645
- PMCID: PMC4183548
- DOI: 10.1371/journal.pone.0109102
Characterization of fibrillar collagens and extracellular matrix of glandular benign prostatic hyperplasia nodules
Abstract
Objective: Recent studies have associated lower urinary tract symptoms (LUTS) in men with prostatic fibrosis, but a definitive link between collagen deposition and LUTS has yet to be demonstrated. The objective of this study was to evaluate ECM and collagen content within normal glandular prostate tissue and glandular BPH, and to evaluate the association of clinical parameters of LUTS with collagen content.
Methods: Fibrillar collagen and ECM content was assessed in normal prostate (48 patients) and glandular BPH nodules (24 patients) using Masson's trichrome stain and Picrosirius red stain. Second harmonic generation (SHG) imaging was used to evaluate collagen content. Additional BPH tissues (n = 47) were stained with Picrosirius red and the association between clinical parameters of BPH/LUTS and collagen content was assessed.
Results: ECM was similar in normal prostate and BPH (p = 0.44). Total collagen content between normal prostate and glandular BPH was similar (p = 0.27), but a significant increase in thicker collagen bundles was observed in BPH (p = 0.045). Using SHG imaging, collagen content in BPH (mean intensity = 62.52; SEM = 2.74) was significantly higher than in normal prostate (51.77±3.49; p = 0.02). Total collagen content was not associated with treatment with finasteride (p = 0.47) or α-blockers (p = 0.52), pre-TURP AUA symptom index (p = 0.90), prostate-specific antigen (p = 0.86), post-void residual (PVR; p = 0.32), prostate size (p = 0.21), or post-TURP PVR (p = 0.51). Collagen content was not associated with patient age in patients with BPH, however as men aged normal prostatic tissue had a decreased proportion of thick collagen bundles.
Conclusions: The proportion of larger bundles of collagen, but not total collagen, is increased in BPH nodules, suggesting that these large fibers may play a role in BPH/LUTS. Total collagen content is independent of clinical parameters of BPH and LUTS. If fibrosis and overall ECM deposition are associated with BPH/LUTS, this relationship likely exists in regions of the prostate other than glandular hyperplasia.
Conflict of interest statement
Figures
References
-
- Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P (2011) Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU International 108: 1132–1138. - PubMed
-
- Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, et al. (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourology and Urodynamics 21: 167–178. - PubMed
-
- Nickel JC (2006) BPH: costs and treatment outcomes. American Journal of Managed Care 12: S141–148. - PubMed
-
- Chapple CR, Roehrborn CG (2006) A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder. European Urology 49: 651–658. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA123199/CA/NCI NIH HHS/United States
- R01-DK093690/DK/NIDDK NIH HHS/United States
- K01-DK083425/DK/NIDDK NIH HHS/United States
- T32-GM07356/GM/NIGMS NIH HHS/United States
- R01-CA123199/CA/NCI NIH HHS/United States
- F30 DK093173/DK/NIDDK NIH HHS/United States
- R01 DK093690/DK/NIDDK NIH HHS/United States
- U54 DK104310/DK/NIDDK NIH HHS/United States
- P30 CA014520/CA/NCI NIH HHS/United States
- T32 GM007356/GM/NIGMS NIH HHS/United States
- F30-DK093173/DK/NIDDK NIH HHS/United States
- K01 DK083425/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
